Latest Search
Quote
| Back Zoom + Zoom - | ||||
|
<Research>UBS Lowers PA GOODDOCTOR's TP to HKD14.5, Rating Neutral
Recommend 8 Positive 5 Negative 4 |
||||
|
||||
|
PA GOODDOCTOR (01833.HK)'s 2025 revenue grew by 13.7% YoY to RMB5.47 billion, while net profit and non-IFRS net profit amounted to RMB378 million and RMB414 million, respectively, indicating YoY increases of 5.2 ppts and 4.3 ppts in net profit margin and adjusted net profit margin to 6.9% and 7.6%, according to a report from UBS. UBS has raised its EPS forecast for PA GOODDOCTOR for each year from 2026 to 2028 to RMB0.22, RMB0.31, and RMB0.39. PA GOODDOCTOR's target price dropped from HKD16.5 to HKD14.5, with a Neutral rating. AAStocks Financial News |
||||
Copied to Clipboard
 |
||||
